Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $52.70 million. The enterprise value is $63.69 million.
Important Dates
The last earnings date was Friday, November 8, 2024, before market open.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 37.64 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 37.64M |
| Shares Outstanding | 37.64M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.89% |
| Owned by Institutions (%) | 25.65% |
| Float | 28.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| Forward PS | 0.97 |
| PB Ratio | 4.39 |
| P/TBV Ratio | 4.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 3.47.
| Current Ratio | 5.46 |
| Quick Ratio | 4.30 |
| Debt / Equity | 3.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.97 |
Financial Efficiency
Return on equity (ROE) is -127.39% and return on invested capital (ROIC) is -27.19%.
| Return on Equity (ROE) | -127.39% |
| Return on Assets (ROA) | -22.18% |
| Return on Capital (ROIC) | -27.19% |
| Revenue Per Employee | $192,627 |
| Profits Per Employee | -$112,865 |
| Employee Count | 252 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, Apyx Medical has paid $250,000 in taxes.
| Income Tax | 250,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.67% in the last 52 weeks. The beta is 1.21, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -41.67% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.45 |
| Relative Strength Index (RSI) | 59.37 |
| Average Volume (20 Days) | 67,122 |
Short Selling Information
The latest short interest is 230,246, so 0.61% of the outstanding shares have been sold short.
| Short Interest | 230,246 |
| Short Previous Month | 234,863 |
| Short % of Shares Out | 0.61% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 5.49 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $48.54 million and -$28.44 million in losses. Loss per share was -$0.82.
| Revenue | 48.54M |
| Gross Profit | 29.33M |
| Operating Income | -21.32M |
| Pretax Income | -28.50M |
| Net Income | -28.44M |
| EBITDA | -20.71M |
| EBIT | -21.32M |
| Loss Per Share | -$0.82 |
Full Income StatementBalance Sheet
The company has $28.01 million in cash and $38.85 million in debt, giving a net cash position of -$10.83 million or -$0.29 per share.
| Cash & Cash Equivalents | 28.01M |
| Total Debt | 38.85M |
| Net Cash | -10.83M |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 11.20M |
| Book Value Per Share | 0.32 |
| Working Capital | 42.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.32 million and capital expenditures -$570,000, giving a free cash flow of -$17.89 million.
| Operating Cash Flow | -17.32M |
| Capital Expenditures | -570,000 |
| Free Cash Flow | -17.89M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
Gross margin is 60.41%, with operating and profit margins of -43.93% and -58.59%.
| Gross Margin | 60.41% |
| Operating Margin | -43.93% |
| Pretax Margin | -58.25% |
| Profit Margin | -58.59% |
| EBITDA Margin | -42.67% |
| EBIT Margin | -43.93% |
| FCF Margin | -19.94% |